Subtopic Deep Dive

Exosomes as Biomarkers
Research Guide

What is Exosomes as Biomarkers?

Exosomes as biomarkers utilize nano-sized extracellular vesicles carrying proteins, lipids, and nucleic acids for non-invasive detection of diseases including cancer and neurodegeneration.

Exosomes, 30-200 nm vesicles secreted by cells, contain selective cargo profiled via proteomics and miRNA sequencing (Pegtel and Gould, 2019; 2626 citations). MISEV2018 standardizes their study and isolation for biomarker applications (Théry et al., 2018; 10573 citations). Over 10 high-citation papers since 2016 highlight diagnostic potential in multiple cancers (Hoshino et al., 2020; 1160 citations).

Curated Papers

Key Challenges

Why It Matters

Exosome biomarkers enable liquid biopsies surpassing tissue sampling for cancer monitoring (Kalluri, 2016; 1860 citations). Circulating exosomal miRNAs detect early neurodegeneration and cardiovascular risks (Condrat et al., 2020; 1259 citations). Hoshino et al. (2020) identified EV biomarkers across cancers, supporting clinical assays. Yoshioka et al. (2014; 577 citations) developed ExoScreen for ultra-sensitive EV detection in patient plasma.

Key Research Challenges

Standardized Isolation Methods

Exosome purification varies by ultracentrifugation, immunoaffinity, or microfluidics, lacking uniformity (Li et al., 2017; 1848 citations). MISEV2018 addresses this but compliance remains inconsistent (Théry et al., 2018). Variability affects biomarker reproducibility across labs (Konoshenko et al., 2018; 1149 citations).

Cargo Profiling Specificity

Distinguishing disease-specific exosomal proteins/miRNAs from background noise challenges diagnostics (Pegtel and Gould, 2019). He et al. (2014; 483 citations) used microfluidics for immunoisolation but specificity needs enhancement. Hoshino et al. (2020) defined multi-cancer markers yet tissue-origin tracing persists.

Preanalytical Variability

Circulating miRNA/exosome stability varies by collection, storage, and hemolysis (McDonald et al., 2011; 649 citations). Hannafon and Ding (2013; 514 citations) noted exosome miRNA roles in cancer but preanalytical factors confound measurements. Standardization lags for clinical translation.

Essential Papers

Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines

Clotilde Théry, Kenneth W. Witwer, Elena Aïkawa et al. · 2018 · Journal of Extracellular Vesicles · 10.6K citations

ABSTRACT The last decade has seen a sharp increase in the number of scientific publications describing physiological and pathological functions of extracellular vesicles (EVs), a collective term co...

Exosomes

D. Michiel Pegtel, Stephen J. Gould · 2019 · Annual Review of Biochemistry · 2.6K citations

Exosomes are small, single-membrane, secreted organelles of ∼30 to ∼200 nm in diameter that have the same topology as the cell and are enriched in selected proteins, lipids, nucleic acids, and glyc...

The biology and function of exosomes in cancer

Raghu Kalluri · 2016 · Journal of Clinical Investigation · 1.9K citations

Humans circulate quadrillions of exosomes at all times. Exosomes are a class of extracellular vesicles released by all cells, with a size range of 40-150 nm and a lipid bilayer membrane. Exosomes c...

Progress in Exosome Isolation Techniques

Pin Li, Melisa Kaslan, Sze Han Lee et al. · 2017 · Theranostics · 1.8K citations

Exosomes are one type of membrane vesicles secreted into extracellular space by most types of cells. In addition to performing many biological functions particularly in cell-cell communication, cum...

RNA delivery by extracellular vesicles in mammalian cells and its applications

Killian P. O’Brien, Koen Breyne, Stefano Ughetto et al. · 2020 · Nature Reviews Molecular Cell Biology · 1.7K citations

Extracellular vesicles as a next-generation drug delivery platform

Inge K. Herrmann, Matthew J. A. Wood, Gregor Fuhrmann · 2021 · Nature Nanotechnology · 1.7K citations

miRNAs as Biomarkers in Disease: Latest Findings Regarding Their Role in Diagnosis and Prognosis

Carmen Elena Condrat, Dana Claudia Thompson, Mădălina Gabriela Barbu et al. · 2020 · Cells · 1.3K citations

MicroRNAs (miRNAs) represent a class of small, non-coding RNAs with the main roles of regulating mRNA through its degradation and adjusting protein levels. In recent years, extraordinary progress h...

Reading Guide

Foundational Papers

Start with Théry et al. (2018; MISEV2018) for EV standardization, then Yoshioka et al. (2014; ExoScreen) and He et al. (2014; microfluidics) for early detection tech.

Recent Advances

Study Hoshino et al. (2020; multi-cancer markers), Condrat et al. (2020; miRNA biomarkers), Zhang et al. (2020; diagnostic applications).

Core Methods

Core techniques: ultracentrifugation (Li et al., 2017), miRNA sequencing (Condrat et al., 2020), immunoisolation (He et al., 2014), ExoScreen (Yoshioka et al., 2014).

How PapersFlow Helps You Research Exosomes as Biomarkers

Discover & Search

Research Agent uses searchPapers and exaSearch to query 'exosome biomarkers cancer MISEV2018' retrieving Théry et al. (2018), then citationGraph maps 10573 citing works and findSimilarPapers uncovers Hoshino et al. (2020) for multi-cancer EV markers.

Analyze & Verify

Analysis Agent applies readPaperContent on Li et al. (2017) to compare isolation yields, verifyResponse with CoVe cross-checks claims against Pegtel and Gould (2019), and runPythonAnalysis processes miRNA seq data from Condrat et al. (2020) with GRADE scoring for prognostic strength.

Synthesize & Write

Synthesis Agent detects gaps in exosome isolation standardization from Théry et al. (2018) vs. Konoshenko et al. (2018), flags contradictions in cargo specificity; Writing Agent uses latexEditText, latexSyncCitations for biomarker review, and latexCompile generates figures with exportMermaid for isolation workflow diagrams.

Use Cases

"Compare exosome isolation yields from ultracentrifugation vs. microfluidics in cancer biomarker studies"

Research Agent → searchPapers('exosome isolation cancer') → Analysis Agent → readPaperContent(Li et al. 2017) + runPythonAnalysis(pandas on yield tables) → researcher gets CSV of normalized yields with statistical p-values.

"Draft LaTeX review on exosomal miRNAs in neurodegeneration diagnostics"

Synthesis Agent → gap detection(Condrat et al. 2020, Hannafon 2013) → Writing Agent → latexEditText + latexSyncCitations(10 papers) + latexCompile → researcher gets compiled PDF with synced bibtex and miRNA pathway figure.

"Find GitHub code for ExoScreen EV quantification from Yoshioka 2014"

Research Agent → paperExtractUrls(Yoshioka et al. 2014) → paperFindGithubRepo → Code Discovery → githubRepoInspect → researcher gets validated Python scripts for EV detection analysis with NumPy integration.

Automated Workflows

Deep Research workflow scans 50+ exosome papers via searchPapers, structures biomarker evidence by disease with GRADE grading from Analysis Agent. DeepScan's 7-step chain verifies MISEV2018 compliance in isolation studies (Théry et al., 2018) using CoVe checkpoints. Theorizer generates hypotheses on exosomal cargo for neurodegeneration from Condrat et al. (2020) literature synthesis.

Try Doxa for Exosomes as Biomarkers Research

Frequently Asked Questions

What defines exosomes as biomarkers?

Exosomes are 30-200 nm vesicles with disease-specific cargo like miRNAs and proteins for non-invasive detection (Pegtel and Gould, 2019).

What are key exosome isolation methods?

Methods include ultracentrifugation, immunoaffinity, and microfluidics; MISEV2018 recommends combinations for purity (Théry et al., 2018; Li et al., 2017).

What are seminal papers on exosomes as biomarkers?

Théry et al. (2018; MISEV2018; 10573 citations), Kalluri (2016; cancer functions; 1860 citations), Hoshino et al. (2020; cancer EV markers; 1160 citations).

What open problems exist in exosome biomarkers?

Challenges include isolation standardization, cargo specificity, and preanalytical stability for clinical assays (Konoshenko et al., 2018; McDonald et al., 2011).